9783540340065 - cell culture engineering: 101 (advances in biochemical engineering/biotechnology) (6 resultados)

Idioma: Inglés
Editorial: Springer, 2006
Serie: Advances in Biochemical Engineering/Biotechnology, Libro 15 de 81. Libro 15 de 81 - Advances in Biochemical Engineering/Biotechnology
- Tapa dura
Librería: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, AlemaniaAntiquariat Thomas Haker GmbH & Co. KG
Contactar con el vendedorVendedor de 5 estrellasMiembro de asociación: GIAQ
Condición: Usado - Excelente
EUR 45,90
Envío por EUR 20,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Hardcover/Pappeinband. Condición: Sehr gut. 179 p. Very good. Shrink wrapped. / Sehr guter Zustand. In Folie verschweißt. Sprache: Englisch Gewicht in Gramm: 798.

Idioma: Inglés
Editorial: Springer, 2006
Serie: Advances in Biochemical Engineering/Biotechnology, Libro 15 de 81. Libro 15 de 81 - Advances in Biochemical Engineering/Biotechnology
- Tapa dura
Librería: Phatpocket Limited, Waltham Abbey, HERTS, Reino UnidoPhatpocket Limited
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Aceptable
EUR 153,52
Envío por EUR 12,35Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.

Idioma: Inglés
Editorial: Springer-Verlag GmbH, 2006
Serie: Advances in Biochemical Engineering/Biotechnology, Libro 15 de 81. Libro 15 de 81 - Advances in Biochemical Engineering/Biotechnology
- Tapa blanda
Librería: Buchpark, Trebbin, AlemaniaBuchpark
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Excelente
EUR 117,12
Envío por EUR 105,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Idioma: Inglés
Editorial: Springer, 2006
Serie: Advances in Biochemical Engineering/Biotechnology, Libro 15 de 81. Libro 15 de 81 - Advances in Biochemical Engineering/Biotechnology
- Tapa dura
Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 311,76
Envío por EUR 13,91Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. In.

Idioma: Inglés
Editorial: Springer Berlin Heidelberg, 2006
Serie: Advances in Biochemical Engineering/Biotechnology, Libro 15 de 81. Libro 15 de 81 - Advances in Biochemical Engineering/Biotechnology
- Tapa dura
Librería: moluna, Greven, Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 336,82
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Gebunden. Condición: New. Covers trends in modern biotechnologyAll aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemical engineering and computer science, are treated.

Idioma: Inglés
Editorial: Springer, Berlin, Springer, 2006
Serie: Advances in Biochemical Engineering/Biotechnology, Libro 15 de 81. Libro 15 de 81 - Advances in Biochemical Engineering/Biotechnology
- Tapa dura
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 413,67
Envío por EUR 62,13Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Buch. Condición: Neu. Neuware - Since the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the ho- zon of health care. Many patients suffering with life-threatening diseases or chronic dysfunctions, which were medically untreatable not long ago, can at…test to the wonder these drugs have achieved. Although the rst generation of p- tein therapeutics was produced in recombinant Escherichia coli, most recent products use mammalian cells as production hosts. Not long after the rst p- duction of recombinant proteins in E. coli, it was realized that the complex tasks of most post-translational modi cations on proteins could only be ef ciently carried out in mammalian cells. In the 1990s, we witnessed a rapid expansion of mammalian-cell-derived protein therapeutics, chie y antibodies. In fact, it has been nearly a decade since the market value of mammalian-cell-derived protein therapeutics surpassed that of those produced from E. coli. A common characteristic of recent antibody products is the relatively large dose required for effective therapy, demanding larger quantities for the treatment of a given disease. This, coupled with the broadening repertoire of protein drugs, has rapidly expanded the quantity needed for clinical applications. The increasing demand for protein therapeutics has not been met exclusively by construction of new manufacturing plants and increasing total volume capacity. More - portantly the productivity of cell culture processes has been driven upward by an order of magnitude in the past decade.